JP Morgan Chase
SKIN icon

JP Morgan Chase’s SkinHealth Systems SKIN Stock Holding History

JP Morgan Chase’s Portfolio SKIN Stock Details SKIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40.7K Buy
49,674
+4,005
+9% +$4.92K ﹤0.01% 6278
2025
Q4 		$63.5K Sell
45,669
-390
-0.8% -$564 ﹤0.01% 6119
2025
Q3 		$91.7K Sell
46,059
-8,167
-15% -$16.6K ﹤0.01% 5950
2025
Q2 		$104K Buy
54,226
+19,032
+54% +$26.8K ﹤0.01% 5589
2025
Q1 		$47.2K Sell
35,194
-2,808
-7% -$4.28K ﹤0.01% 5900
2024
Q4 		$60.4K Buy
38,002
+2,535
+7% +$3.98K ﹤0.01% 5944
2024
Q3 		$51.1K Buy
35,467
+1,764
+5% +$2.89K ﹤0.01% 5980
2024
Q2 		$64.7K Buy
33,703
+1,149
+4% +$3.24K ﹤0.01% 5740
2024
Q1 		$145K Sell
32,554
-22,042
-40% -$71.6K ﹤0.01% 5513
2023
Q4 		$170K Sell
54,596
-47,356
-46% -$178K ﹤0.01% 5481
2023
Q3 		$614K Sell
101,952
-372,196
-78% -$2.61M ﹤0.01% 4364
2023
Q2 		$3.97M Buy
474,148
+352,882
+291% +$3.67M ﹤0.01% 3056
2023
Q1 		$1.53M Buy
121,266
+13,321
+12% +$154K ﹤0.01% 3729
2022
Q4 		$982K Sell
107,945
-45,197
-30% -$488K ﹤0.01% 4050
2022
Q3 		$1.81M Buy
153,142
+16,868
+12% +$213K ﹤0.01% 3561
2022
Q2 		$1.75M Buy
136,274
+26,440
+24% +$354K ﹤0.01% 3656
2022
Q1 		$1.85M Buy
109,834
+15,695
+17% +$259K ﹤0.01% 3820
2021
Q4 		$2.27M Buy
94,139
+48,454
+106% +$1.25M ﹤0.01% 3761
2021
Q3 		$1.19M Buy
45,685
+20,703
+83% +$455K ﹤0.01% 4178
2021
Q2 		$419K Sell
24,982
-104,944
-81% -$1.44M ﹤0.01% 4808
2021
Q1 		$1.4M Sell
129,926
-10,000
-7% -$110K ﹤0.01% 3968
2020
Q4 		$1.58M Buy
+139,926
New +$1.51M ﹤0.01% 3656

Other funds holding SKIN

CFM
Capricorn Fund Managers London, United Kingdom $641M AUM 61.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase's SKIN Position: Q1 2026 in Review

JP Morgan Chase increased its SkinHealth Systems (SKIN) stake by 8.8% in Q1 2026, buying an estimated $4.92K and bringing the position to 49,674 shares worth $40.7K. The position accounts for ﹤0.01% of the portfolio, ranked #6278.

JP Morgan Chase first reported a position in SKIN in Q4 2020 and has held it in 22 quarters since. The position peaked at $3.97M in Q2 2023. 116 funds tracked by Wall St. Rank hold SKIN as of Q1 2026.

  • JP Morgan Chase held 49,674 shares of SkinHealth Systems worth $40.7K as of Q1 2026.
  • JP Morgan Chase bought 4,005 SkinHealth Systems shares in Q1 2026, an estimated $4.92K.
  • SkinHealth Systems made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6278 holding.
  • JP Morgan Chase first reported a position in SkinHealth Systems in Q4 2020 and has held it in 22 quarters since.
  • JP Morgan Chase's SkinHealth Systems position peaked at $3.97M in Q2 2023.
  • 116 funds tracked by Wall St. Rank held SkinHealth Systems as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.